Home
Conditions
Triple Negative Breast Cancer

Clinical trial condition

Triple Negative Breast Cancer

Explore clinical trials studying Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

298 public trials 111 recruiting studies

Refine in advanced search Browse all conditions

Triple Negative Breast Cancer trial results

Recruiting

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

NCT07261631

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +30 more
Locations: Novartis Investigative Site Montreal, Quebec, Canada

Novartis Investigative Site Odense C, Denmark

Novartis Investigative Site Vandœuvre-lès-Nancy, France

Novartis Investigative Site Essen, Germany

View Trial Details

Recruiting

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

NCT05076760

Conditions: Adenocarcinoma, Advanced Cancer, Breast Diseases, +50 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

Duke Cancer Institute Durham, North Carolina, United States

View Trial Details

Recruiting

ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer

NCT06224673

Conditions: Breast Diseases, Breast Neoplasms, HER2 Low Breast Carcinoma, +8 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Recruiting

Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer

NCT06631092

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: University Clinic Erlangen Erlangen, Germany

National Center for Tumor Diseases Heidelberg Heidelberg, Germany

View Trial Details

Recruiting

Investigating Datopotamab Deruxtecan Plus Durvalumab Versus Datopotamab Deruxtecan in Patients With PDL1-negative Metastatic Triple-negative Breast Cancer

NCT06954480

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Barts Cancer Institute, Centre of Experimental Cancer Medicine London, United Kingdom

Barts Health NHS Trust London, United Kingdom

View Trial Details

Recruiting

A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer

NCT05989828

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Recruiting

Neoadjuvant Serplulimab Plus Weekly Paclitaxel and Carboplatin in TNBC (Neo-SERPENT)

NCT07283692

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Renji Hospital, School of Medicine, Shanghai Jiaotong University Shanghai, China

View Trial Details

Recruiting

A Study of SKB264 Versus Investigator's Choice Chemotherapy in Patients With Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer

NCT06279364

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

MicroRNA Profiles in Triple Negative Breast Cancer

NCT04771871

Conditions: Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, +10 more
Locations: Obafemi Awolowo University Teaching Hospital Ile-Ife, Oshun, Nigeria

University College Hospital Ibadan, Oyo State, Nigeria

Lagos State University Teaching Hospital Lagos, Nigeria

Lagos University Teaching Hospital Lagos, Nigeria

View Trial Details

Recruiting

NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients

NCT06845319

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Medical University of South Carolina Charleston, South Carolina, United States

View Trial Details

Triple Negative Breast Cancer

Triple Negative Breast Cancer trial results

Related conditions